Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Immunology

• Publication date

  2011-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.0903490PMID 21576510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection

  2009cited by this paper
• T Cell Responses to Whole SARS Coronavirus in Humans1

  2008cited by this paper
• Duration of Antibody Responses after Severe Acute Respiratory Syndrome

  2007cited by this paper
• Disappearance of antibodies to SARS-associated coronavirus after recovery.

  2007influential reference
• Antibodies and B cell memory in viral immunity.

  2007cited by this paper
• Duration of humoral immunity to common viral and vaccine antigens.

  2007cited by this paper
• Differentiation of memory B and T cells.

  2006cited by this paper
• Two-Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome

  2006cited by this paper
• Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients

  2006cited by this paper
• Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals

  2005cited by this paper
• Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein

  2005cited by this paper
• Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome

  2005cited by this paper
• Compromised B cell responses to influenza vaccination in HIV-infected individuals.

  2005cited by this paper
• Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

  2005cited by this paper
• Severe Acute Respiratory Syndrome

  2004cited by this paper
• A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

  2004cited by this paper
• Immunological memory in humans.

  2004cited by this paper
• Detection and Enumeration of Circulating HIV-1–Specific Memory B Cells in HIV-1–Infected Patients

  2004cited by this paper
• Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

  2004influential reference
• Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection.

  2004cited by this paper
• Identification of Immunodominant Sites on the Spike Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Implication for Developing SARS Diagnostics and Vaccines

  2004cited by this paper
• Severe acute respiratory syndrome

  2004cited by this paper
• Duration of antiviral immunity after smallpox vaccination

  2003cited by this paper
• The Severe Acute Respiratory Syndrome

  2003cited by this paper
• Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1

  2003cited by this paper
• Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients.

  2003cited by this paper
• Lung pathology of fatal severe acute respiratory syndrome

  2003cited by this paper
• Antibodies, viruses and vaccines

  2002cited by this paper
• Diagnosis and management of smallpox.

  2002cited by this paper
• A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria.

  1999cited by this paper
• Humoral immunity due to long-lived plasma cells.

  1998cited by this paper
• Lifetime of plasma cells in the bone marrow

  1997cited by this paper
• Immunological Memory and Protective Immunity: Understanding Their Relation

  1996cited by this paper
• Germinal Centers and Antibody Production in Bone Marrow

  1992cited by this paper

• The structure and function of membrane protein in coronavirus infection and its applications in the development of vaccines and therapeutic drugs.

  2026cites this paper
• Design of a Multi-Valent SARS-CoV-2 Peptide Vaccine for Broad Immune Protection via Deep Learning

  2025cites this paper
• CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway

  2025cites this paper
• CKD-related impairment in humoral and cellular immune response and potential correlation with long COVID-19: a systematic review

  2025cites this paper
• Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels

  2025influential citation
• A novel protocol for detection and quantification of SARS-CoV-2 virus based on settlement rates of clay-virus-electrolyte mixture

  2025cites this paper
• The Influence of Cross-Reactive T Cells in COVID-19

  2024cites this paper
• Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic

  2024influential citation
• Mucosal immunity in upper and lower respiratory tract to MERS-CoV

  2024cites this paper
• Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections

  2024cites this paper
• DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice

  2024cites this paper
• Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes

  2024cites this paper
• The molecular mechanisms of CD8+ T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions

  2024cites this paper
• Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions

  2024cites this paper
• Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells

  2024cites this paper
• Advanced biomaterials for regenerative medicine and their possible therapeutic significance in treating COVID-19: a critical overview

  2024cites this paper
• T Cell Responses to SARS-CoV-2 in Vaccinated Pregnant Women: A Comparative Study of Pre-Pregnancy and During-Pregnancy Infections

  2024cites this paper
• Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

  2023cites this paper
• Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate

  2023cites this paper
• Risk of SARS-CoV-2 transmission in the close contacts in a small rural area in the Veneto Region (NE-Italy): past evidence for future scenarios

  2023cites this paper
• Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2

  2023cites this paper
• Design and Assessment of a Novel In Silico Approach for Developing a Next-Generation Multi-Epitope Universal Vaccine Targeting Coronaviruses

  2023cites this paper
• Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic

  2023cites this paper
• Effect of probiotics as an immune modulator for the management of COVID-19

  2023cites this paper
• mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection

  2023cites this paper
• Performance of T-Track® SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells

  2023cites this paper
• Coarse-grained molecular dynamics-guided immunoinformatics to explain the binder and non-binder classification of Cytotoxic T-cell epitope for SARS-CoV-2 peptide-based vaccine discovery

  2023cites this paper
• Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

  2023cites this paper
• Early protective effect of a (“pan”) coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration

  2023cites this paper
• Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice

  2023cites this paper
• Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients

  2023cites this paper
• Review Paper Immune System Vs. SARS-CoV-2

  2023cites this paper
• Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak

  2023cites this paper
• HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review

  2023cites this paper
• Evolution of SARS-CoV-2-specific CD4+ T cell epitopes

  2023cites this paper
• Multiomic characterisation of the long-term sequelae of SARS survivors: a clinical observational study

  2023cites this paper
• Defending against SARS-CoV-2: The T cell perspective

  2023cites this paper
• Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19

  2023cites this paper
• Role of T cells in severe COVID-19 disease, protection, and long term immunity

  2023cites this paper
• Immune cell landscape in symptomatic and asymptomatic SARS-CoV-2 infected adults and children in urban Dhaka, Bangladesh

  2023cites this paper
• Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine

  2023cites this paper
• Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers

  2023cites this paper
• Viral rebound among patients receiving COVID-19 convalescent plasma for treatment of Covid-19 in Uganda.

  2023cites this paper
• COVID-19: Pathogenesis and Clinical Manifestations

  2022cites this paper
• Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2

  2022cites this paper
• Maintaining immunological memory to the SARS-CoV-2 virus during a pandemic

  2022cites this paper
• Immunopathogenecity in COVID-19

  2022cites this paper
• Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19

  2022cites this paper
• Immunity and Therapeutic Approaches against Coronavirus Disease 2019

  2022cites this paper
• Immune response induced by novel coronavirus infection

  2022cites this paper
• The role of B cells in COVID-19 infection and vaccination

  2022cites this paper
• CD8+ T-cell immune escape by SARS-CoV-2 variants of concern

  2022cites this paper
• Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors

  2022cites this paper
• Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants

  2022cites this paper
• The T Cell Epitope Landscape of SARS-CoV-2 Variants of Concern

  2022cites this paper
• Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice

  2022cites this paper
• In vitro study on efficacy of PHELA, an African traditional drug against SARS-CoV-2

  2022cites this paper
• Comparison of the humoral and cellular immunity in COVID-19 convalescents

  2022cites this paper
• mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273

  2022cites this paper
• Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID

  2022cites this paper
• SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors

  2022cites this paper
• Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection

  2022cites this paper
• Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain

  2022cites this paper
• Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug

  2022cites this paper
• Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19

  2022cites this paper
• Protective and pathogenic role of humoral responses in COVID-19

  2022cites this paper
• Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination

  2022cites this paper
• Adaptive Immune Responses and Immunity to SARS-CoV-2

  2022cites this paper
• Possible Cross Reactivity of Feline and White-tailed Deer Antibodies Against the SARS-CoV-2 Receptor Binding Domain

  2022cites this paper
• T cell responses to SARS-CoV-2 in humans and animals

  2022cites this paper
• In-depth analysis of SARS-CoV-2–specific T cells reveals diverse differentiation hierarchies in vaccinated individuals

  2022cites this paper
• Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines

  2022cites this paper
• Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection

  2022cites this paper
• Enhanced SARS-CoV-2-Specific CD4+ T Cell Activation and Multifunctionality in Late Convalescent COVID-19 Individuals

  2022cites this paper
• The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination

  2022cites this paper
• Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record

  2022cites this paper
• SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases

  2022cites this paper
• B-Cell Responses in Hospitalized Severe Acute Respiratory Syndrome Coronavirus 2–Infected Children With and Without Multisystem Inflammatory Syndrome

  2022cites this paper
• Human Challenge Studies with Coronaviruses Old and New.

  2022cites this paper
• Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates

  2022cites this paper
• Covid-19, an unfinished story

  2022cites this paper
• MERS-CoV Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals

  2022cites this paper
• The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection

  2022cites this paper
• Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations

  2022cites this paper
• Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study

  2022cites this paper
• Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination

  2022cites this paper
• Journal Pre-proof SARS-CoV-2 specific CD4+ T cell longevity correlates with Th17-like phenotype

  2022cites this paper
• Vaccines and autoimmunity during the COVID-19 pandemic

  2022cites this paper
• SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4+ T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer

  2022cites this paper
• Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon

  2022cites this paper
• The T cell immune response against SARS-CoV-2

  2022cites this paper
• Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum

  2022cites this paper
• Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein

  2022cites this paper
• Peculiarities of the T Cell Immune Response in COVID-19

  2022cites this paper
• Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients

  2022cites this paper
• The impact of lymphoid memory cells in different ages of COVID-19 patients

  2022cites this paper
• Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity

  2022cites this paper
• Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity

  2022influential citation
• Unresolved questions in the zoonotic transmission of MERS

  2022cites this paper
• Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients With Different Severities

  2022cites this paper